Jens Faber: Clinical Trials

2 trials sponsored by Jens Faber, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 41Completed 1

Follow Jens Faber: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LIPT - Liraglutide in Polycystic Ovary Syndrome
Liraglutide for 26 weeks, placebo - Polycystic Ovary Syndrome, Cardiovascular Disease
Phase 4CompletedJens Faber722014-03-012019-02-28
Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)
Liothyronine - Heart Failure, Low T3 Syndrome
Not applicableCompletedJens Faber212011-07-012019-07-16

Conditions studied

Cardiovascular Diseases (1)  ·  Euthyroid Sick Syndromes (1)  ·  Heart Failure (1)  ·  Polycystic Ovary Syndrome (1)

Interventions

Liraglutide (1)  ·  Triiodothyronine (1)

Countries

Denmark (2)

Results publications

PMID 28681988